A probiotic bacteria called Bacillus subtilis pb2441 partially reduced fat buildup in the livers of mice eating an unhealthy Western diet, working through similar genetic pathways as the diabetes medication dapagliflozin. According to Gram Research analysis, the probiotic reduced genes involved in fat storage while restoring genes that burn fat, though it was less effective than the pharmaceutical treatment. This early-stage research suggests probiotics might help protect liver health, but human studies are needed before recommending it as a treatment.
Researchers tested a specific probiotic bacteria called Bacillus subtilis pb2441 on mice fed a Western diet high in unhealthy foods. According to Gram Research analysis, this probiotic partially reduced fat buildup in the liver and changed how genes work in ways similar to a diabetes medication called dapagliflozin. While the probiotic didn’t work quite as well as the medication, it showed promise as a natural approach to fighting nonalcoholic fatty liver disease, a condition where fat accumulates in the liver and can cause inflammation and damage. The findings suggest probiotics might become a useful tool alongside other treatments for this increasingly common health problem.
Key Statistics
A 2026 research article in Scientific Reports found that Bacillus subtilis pb2441 partially attenuated hepatic steatosis in mice fed a Western diet, with transcriptomic changes broadly similar to the diabetes medication dapagliflozin.
Research showed that the probiotic bacteria reduced lipogenesis-related gene expression while restoring β-oxidation genes in mouse livers, though to a lesser extent than dapagliflozin treatment.
A 2026 study demonstrated that hepatic lipid accumulation was positively associated with inflammation scores and fibrosis-related gene expression, suggesting that reducing liver fat through probiotic treatment might prevent downstream liver damage.
The Quick Take
- What they studied: Whether a specific probiotic bacteria could reduce fat buildup in the liver of mice eating an unhealthy Western-style diet, and how it compared to a diabetes drug
- Who participated: Laboratory mice fed a Western diet (high in fat and processed foods) to mimic how many people eat. The study compared three groups: mice eating normal food, mice eating Western diet only, and mice eating Western diet plus either the probiotic or the medication
- Key finding: The probiotic bacteria partially reduced liver fat and changed how liver genes worked in ways similar to the diabetes medication, though not quite as effectively
- What it means for you: This research suggests probiotics might help protect your liver from fat buildup caused by unhealthy eating habits. However, this is early-stage research in mice, so it’s too soon to recommend probiotics as a treatment. Talk to your doctor before using probiotics for liver health
The Research Details
Scientists fed mice a Western diet (similar to fast food and processed foods that many people eat) to create fatty liver disease. They then gave some mice a probiotic bacteria called Bacillus subtilis pb2441 and others a diabetes medication called dapagliflozin. They measured how much fat accumulated in the livers and examined which genes turned on and off in liver cells.
The researchers used two main ways to look at the results: they stained liver tissue to see fat deposits under a microscope, and they analyzed gene expression to understand how the bacteria and medication changed how liver cells work. This approach let them see both the physical changes in the liver and the molecular changes happening inside cells.
By comparing the probiotic to an established medication, the researchers could evaluate whether the natural approach worked similarly to a proven pharmaceutical treatment. This comparison helps scientists understand if probiotics might be a useful alternative or addition to existing medicines.
This research matters because fatty liver disease is becoming increasingly common in people who eat unhealthy diets, and current treatment options are limited. By testing a probiotic approach, scientists are exploring whether natural, safe interventions might help prevent or reduce this disease. Understanding how probiotics work at the genetic level helps researchers develop better treatments and could eventually lead to new options for people struggling with liver health.
This study was published in Scientific Reports, a reputable peer-reviewed journal. The researchers used multiple methods to measure results (visual staining and gene analysis), which strengthens confidence in the findings. However, this is animal research in mice, so results may not directly apply to humans. The study doesn’t specify the exact number of mice used, which makes it harder to assess statistical power. More research in humans would be needed before recommending this probiotic for treatment
What the Results Show
Mice eating a Western diet developed significant fat buildup in their livers, increased liver weight, and changes in genes related to fat storage and inflammation. When given the probiotic bacteria, these mice showed partial improvement: liver fat decreased, genes involved in fat storage were reduced, and genes involved in fat burning were restored.
The probiotic’s effects were broadly similar to the diabetes medication dapagliflozin, which is already used to treat metabolic diseases. Both treatments reduced liver triglycerides (a type of fat), though the medication worked somewhat more effectively than the probiotic. The probiotic appeared to work by changing how genes control fat metabolism in the liver—specifically by reducing the genes that make fat and boosting the genes that burn fat.
The researchers also found that liver fat accumulation was connected to inflammation and liver damage markers. This suggests that reducing fat in the liver through the probiotic might help prevent the inflammation and scarring that often follows fatty liver disease.
The study showed that the probiotic and medication both reduced inflammation-related gene expression in the liver. Fibrosis-related genes (genes involved in liver scarring) were also affected by the treatments. Serum ALT levels, which indicate liver damage, were associated with the amount of fat in the liver, suggesting that reducing fat might protect against liver injury. The probiotic’s effects on gene expression patterns were remarkably similar to the medication’s effects, even though the probiotic worked less powerfully overall.
This research builds on growing evidence that probiotics can influence metabolic health and liver function. Previous studies have suggested that gut bacteria affect how the body processes fat and manages inflammation. This study is notable because it directly compares a probiotic to an established pharmaceutical treatment, providing a clearer picture of the probiotic’s potential. The findings align with emerging research showing that natural interventions can sometimes mimic pharmaceutical effects, though usually with less dramatic results.
This study was conducted in mice, not humans, so results may not directly translate to people. The exact number of mice used wasn’t specified, making it difficult to assess the statistical strength of the findings. The study only looked at short-term effects; long-term safety and effectiveness remain unknown. The probiotic worked less effectively than the medication, so it may not be a complete replacement for existing treatments. Additionally, the study doesn’t explain exactly how the probiotic bacteria influence the liver—the mechanism of action remains unclear
The Bottom Line
Based on this research, probiotics cannot yet be recommended as a treatment for fatty liver disease. The evidence is promising but limited to animal studies. If you have fatty liver disease or are concerned about liver health, consult your doctor about proven treatments and lifestyle changes like diet improvement and exercise. You might ask your doctor whether probiotics could be a helpful addition to your overall health plan, but don’t rely on them as a primary treatment (Confidence level: Low to Moderate)
People with fatty liver disease or those at risk (overweight, diabetic, or eating unhealthy diets) should follow this research. Healthcare providers treating metabolic diseases may find this interesting for future treatment development. People interested in natural health approaches might appreciate the potential of probiotics, but should understand this is very early research. People without liver disease don’t need to change their behavior based on this single study
If probiotics eventually become a treatment option, benefits would likely take weeks to months to appear, similar to other metabolic interventions. This research is in early stages; human clinical trials would need to happen before any probiotic could be recommended for fatty liver disease treatment. Realistic timeline: 5-10 years before this might become an available treatment option
Frequently Asked Questions
Can probiotics help treat fatty liver disease?
Research shows probiotics may help reduce liver fat buildup, but current evidence is limited to animal studies. A 2026 study found Bacillus subtilis pb2441 partially reduced liver fat in mice, though less effectively than pharmaceutical treatments. Talk to your doctor before using probiotics for liver disease.
How does the probiotic bacteria work to reduce liver fat?
The probiotic appears to work by changing how genes control fat metabolism in the liver. It reduces genes that create fat while boosting genes that burn fat, similar to how a diabetes medication works. The exact mechanism in humans remains unclear.
Is this probiotic better than medication for fatty liver disease?
No. Research shows the probiotic worked less effectively than dapagliflozin, a diabetes medication. While the probiotic showed promise, it only partially reduced liver fat. Established medications remain more effective, though this probiotic might eventually complement existing treatments.
When will this probiotic be available as a treatment?
This research is in early stages using mice. Human clinical trials would need to occur before any probiotic could be recommended for treatment. Realistically, this could take 5-10 years or longer to develop into an approved therapy.
What should I do if I have fatty liver disease?
Consult your doctor about proven treatments including diet improvement, exercise, and weight loss. While probiotics show potential, current evidence doesn’t support using them as primary treatment. Your doctor can recommend evidence-based approaches suited to your specific situation.
Want to Apply This Research?
- Track daily probiotic intake (if recommended by your doctor) alongside liver health markers: note any fatigue, abdominal discomfort, or changes in digestion. If you have access to liver function tests (ALT levels), log results quarterly to monitor trends
- If your doctor approves, add a probiotic supplement containing Bacillus subtilis or similar strains to your daily routine. Pair this with documented dietary improvements (reducing processed foods, increasing vegetables) and weekly exercise to create a comprehensive liver health plan
- Work with your healthcare provider to monitor liver health through periodic blood tests measuring ALT and other liver enzymes. Keep a food diary to track diet quality alongside any probiotic use. Document energy levels and digestive changes monthly to assess overall impact
This research is preliminary and was conducted in mice, not humans. Probiotics should not be used to replace proven medical treatments for fatty liver disease. If you have fatty liver disease or are concerned about your liver health, consult with a qualified healthcare provider before starting any probiotic supplement. This article is for educational purposes only and should not be considered medical advice. Always discuss new supplements or treatments with your doctor, especially if you take medications or have existing health conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.